AFFINIA THERAPEUTICS Trademark

Trademark Overview


On Tuesday, January 30, 2024, a trademark application was filed for AFFINIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AFFINIA THERAPEUTICS trademark a serial number of 98383243. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, March 11, 2025. This trademark is owned by Affinia Therapeutics Inc.. The AFFINIA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; engineering services to develop vectors and gene therapy products; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
affinia therapeutics

General Information


Serial Number98383243
Word MarkAFFINIA THERAPEUTICS
Filing DateTuesday, January 30, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLETHERAPEUTICS
Goods and ServicesResearch and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; engineering services to develop vectors and gene therapy products; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 30, 2024
Primary Code042
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateTuesday, March 31, 2020

Trademark Owner History


Party NameAffinia Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Tuesday, January 30, 2024NEW APPLICATION ENTERED
Thursday, May 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 7, 2024NON-FINAL ACTION WRITTEN
Saturday, September 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 7, 2024NON-FINAL ACTION E-MAILED
Friday, August 23, 2024ASSIGNED TO EXAMINER
Monday, December 9, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, December 9, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 12, 2025ASSIGNED TO LIE
Tuesday, March 11, 2025SUSPENSION LETTER WRITTEN
Tuesday, March 11, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, March 11, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 6, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 6, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 6, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 6, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED